NO20044390L - Fosinoprilformulering - Google Patents

Fosinoprilformulering

Info

Publication number: NO20044390L
Authority: NO; Norway
Prior art keywords: fosinopril; formulation; fosinoprilformulering; fosinoprilat; ace
Prior art date: 2002-03-19

Application number

NO20044390A

Other languages

English (en)

Norwegian (no)

Inventor

Reynir Eyjolfsson

Original Assignee

Actavis Group Hf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-19

Filing date

2004-10-18

Publication date

2004-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36715398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044390(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-10-18 Application filed by Actavis Group Hf filed Critical Actavis Group Hf

2004-12-15 Publication of NO20044390L publication Critical patent/NO20044390L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20044390A 2002-03-19 2004-10-18 Fosinoprilformulering NO20044390L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IS6315A IS1935B (is)	2002-03-19	2002-03-19	Fósínópríl lyfjasamsetning
PCT/IS2003/000013 WO2003077929A1 (en)	2002-03-19	2003-03-19	Fosinopril formulation

Publications (1)

Publication Number	Publication Date
NO20044390L true NO20044390L (no)	2004-12-15

Family

ID=36715398

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044390A NO20044390L (no)	2002-03-19	2004-10-18	Fosinoprilformulering

Country Status (13)

Country	Link
US (1)	US7045511B2 (is)
EP (1)	EP1531831B1 (is)
AT (1)	ATE314076T1 (is)
AU (1)	AU2003208599A1 (is)
DE (1)	DE60303041T2 (is)
DK (1)	DK1531831T3 (is)
EA (1)	EA008171B1 (is)
ES (1)	ES2256721T3 (is)
IS (1)	IS1935B (is)
NO (1)	NO20044390L (is)
PT (1)	PT1531831E (is)
UA (1)	UA78988C2 (is)
WO (1)	WO2003077929A1 (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1635792E (pt) *	2003-06-26	2009-05-15	Teva Pharma	Composições farmacêuticas estáveis de derivados do ácido 2-aza-biciclo[3.3.0]octano-3-carboxílico
US20050095287A1 (en) *	2003-10-29	2005-05-05	Matharu Amol S.	Fosinopril composition
GB2411355B (en)	2004-02-27	2006-02-22	Niche Generics Ltd	Pharmaceutical composition
WO2006086734A1 (en) *	2005-02-11	2006-08-17	Aventis Pharmaceuticals Inc.	Substituted propane phosphinic acid esters
WO2006100602A2 (en) *	2005-03-22	2006-09-28	Aurobindo Pharma Ltd	Immediate release stable solid oral dosage forms op fosinopril
BRPI0710172A2 (pt) *	2006-04-19	2011-08-23	Teva Pharma	composição farmacêutica estável de ácido carboxìlico derivado de 2-aza-biciclo[3,3,0]-octana-3
GB0612540D0 (en) *	2006-06-23	2006-08-02	Novartis Ag	Galenical formulations of organic compounds
EP1889629B1 (en) *	2006-07-10	2008-08-27	Teva Pharmaceutical Industries Ltd	Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof
US20140179712A1 (en) *	2012-12-21	2014-06-26	Astrazeneca Ab	Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4337201A (en) *	1980-12-04	1982-06-29	E. R. Squibb & Sons, Inc.	Phosphinylalkanoyl substituted prolines
US5006344A (en) *	1989-07-10	1991-04-09	E. R. Squibb & Sons, Inc.	Fosinopril tablet formulations
US6521647B2 (en) *	2000-04-04	2003-02-18	Pfizer Inc.	Treatment of renal disorders
CA2330904C (en) *	2001-01-11	2006-10-24	Bernard Charles Sherman	Fosinopril sodium tablet formulation
PL370599A1 (en) *	2001-11-02	2005-05-30	Pfizer Products Inc.	Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
ITMI20012366A1 (it) *	2001-11-09	2003-05-09	Farmatron Ltd	Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali

2002
- 2002-03-19 IS IS6315A patent/IS1935B/is unknown
2003
- 2003-03-19 DK DK03706893T patent/DK1531831T3/da active
- 2003-03-19 UA UA20041008392A patent/UA78988C2/uk unknown
- 2003-03-19 US US10/507,918 patent/US7045511B2/en not_active Expired - Fee Related
- 2003-03-19 WO PCT/IS2003/000013 patent/WO2003077929A1/en not_active Application Discontinuation
- 2003-03-19 ES ES03706893T patent/ES2256721T3/es not_active Expired - Lifetime
- 2003-03-19 EP EP03706893A patent/EP1531831B1/en not_active Expired - Lifetime
- 2003-03-19 AT AT03706893T patent/ATE314076T1/de active
- 2003-03-19 DE DE60303041T patent/DE60303041T2/de not_active Expired - Lifetime
- 2003-03-19 PT PT03706893T patent/PT1531831E/pt unknown
- 2003-03-19 AU AU2003208599A patent/AU2003208599A1/en not_active Abandoned
- 2003-03-19 EA EA200401218A patent/EA008171B1/ru not_active IP Right Cessation
2004
- 2004-10-18 NO NO20044390A patent/NO20044390L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ATE314076T1 (de)	2006-01-15
WO2003077929A1 (en)	2003-09-25
EA200401218A1 (ru)	2005-12-29
EA008171B1 (ru)	2007-04-27
PT1531831E (pt)	2006-05-31
UA78988C2 (en)	2007-05-10
EP1531831B1 (en)	2005-12-28
ES2256721T3 (es)	2006-07-16
DE60303041D1 (de)	2006-02-02
EP1531831A1 (en)	2005-05-25
DK1531831T3 (da)	2006-05-15
IS6315A (is)	2003-09-20
IS1935B (is)	2004-06-16
DE60303041T2 (de)	2006-08-24
US20050256086A1 (en)	2005-11-17
AU2003208599A1 (en)	2003-09-29
US7045511B2 (en)	2006-05-16

Publication	Publication Date	Title
CO5590918A2 (es)	2005-12-30	Formulaciones
CY1109457T1 (el)	2014-08-13	Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει
MXPA04004464A (es)	2004-08-11	Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
MY138252A (en)	2009-05-29	Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
ATE529430T1 (de)	2011-11-15	Caspase-hemmer-propharmaka
MA29858B1 (fr)	2008-10-03	Derives de carbamoylbenzotriazole en tant qu'inhibiteurs de lipases et phospholipases
NO20060847L (no)	2006-02-21	Substituert 2-aminotetralin til behandling av depresjon
IS7817A (is)	2005-04-20	Fenýlalanín afleiður sem dípeptidýl peptíðasa hindrar til að meðhöndla eða fyrirbyggja sykursýki.
BRPI0518904A2 (pt)	2008-12-16	formulaÇÕes de nepafenac tàpicas
EA200501268A1 (ru)	2006-02-24	Ингибирующие вич 1,2,4-триазины
MY151295A (en)	2014-04-30	Pyrimidyl indoline compound
ATE554084T1 (de)	2012-05-15	N-hydroxyacrylamidverbindungen
MX2009003926A (es)	2009-06-26	Composiciones de fenilalquilamino-carbamato.
NO20074544L (no)	2007-11-08	Inhibering av HER2-losriving med matriksmetalloproteaseantagonister
MA29278B1 (fr)	2008-02-01	Composition pharmaceutique comprenant un derive de l'indolylmaleimide
TNSN06012A1 (en)	2007-10-03	Emulsifying systems containing azetidine derivatives
EA200970378A1 (ru)	2009-10-30	Композиции фенилалкилкарбамата
MXPA04006266A (es)	2004-09-27	Pirimidotriazinas como inhibidores de fosfatasa.
DE60303041D1 (de)	2006-02-02	Fosinopril-formulierung
BR0112245B1 (pt)	2013-09-10	Éster de ácido 4-alcóxi-ciclohexano-1-amino-carboxílico
NO20083183L (no)	2008-09-26	Fast farmasoytisk sammensetning inneholdende irbesartan
WO2008036316A3 (en)	2008-11-06	Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
BRPI0411218A (pt)	2006-07-18	formulações alvejantes fluorescentes estáveis em estocagem
ATE464043T1 (de)	2010-04-15	Pharmazeutische zusammensetzung enthaltend l- arginin
MXPA06000636A (es)	2006-04-19	Formulaciones semi-solidas para la administracion oral de taxoides.

Legal Events

Date	Code	Title	Description
2014-04-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application